Federal Judge Dismisses Lawsuit Against Medicare Drug Price Negotiations

The ruling supports the Biden administration's efforts to lower prescription drug costs under the Inflation Reduction Act.

A federal judge in Texas dismissed a lawsuit by PhRMA challenging Medicare's new drug price negotiation powers.
The lawsuit's dismissal marks a victory for the Biden administration, which seeks to lower drug costs under the Inflation Reduction Act.
Medicare's initial drug price offers to manufacturers for 10 high-cost medications went out earlier this month, with negotiations ongoing.
Drugmakers that refuse to negotiate prices may face withdrawal from Medicare or a hefty excise tax.
The legal battle over Medicare's price negotiation powers could potentially reach the Supreme Court.